GlassScriptPhysician profile
Scott A Colquhoun
NPI 1144200692
$21,826.42
in general payments reported to CMS, 2019-2025
17 companies · $2,525 in 2025
The $2,525 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $404 · 2021: $402 · 2022: $2,555 · 2023: $1,537 · 2024: $4,082 · 2025: $2,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,236 · Travel and Lodging: $3,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,236.39 |
| Travel and Lodging | $3,906.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18,548.74 | 2019-2025 | Journey, Ri Hip Navigation, Journey II |
| Amgen INC. | $813.03 | 2024-2025 | Evenity, Prolia, Prolia |
| Horizon Therapeutics Plc | $765.12 | 2019-2023 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $502.50 | 2022-2025 | Iovera, Zilretta, Exparel |
| Pacira Therapeutics, INC. | $416.22 | 2019-2021 | |
| Stryker Corporation | $226.02 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Perform |
| Heron Therapeutics, INC. | $133.14 | 2023-2024 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $94.62 | 2023 | Persona |
| Sanofi-Aventis U.S. LLC | $66.45 | 2019 | |
| Cornerstone Medical Associates, INC. | $56.50 | 2023-2025 | |
| Boston Scientific Corporation | $45.62 | 2019 | |
| Fidia Pharma USA INC. | $43.35 | 2025 | Hymovis |
| Bioventus LLC | $34.36 | 2019-2021 | |
| Avanos Medical | $24.82 | 2025 | On-Q Pump and Accessories |
| Orthofix Medical, INC. | $21.45 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $21.41 | 2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Colquhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.